Cardiovascular risk markers in patients with primary aldosteronism: A systematic review and meta-analysis of literature studies

International Journal of Cardiology

Volumn 208, Issue , 2016, Pages 46-55

  Ambrosino, Pasquale ^a   Lupoli, Roberta ^a   Tortora, Anna ^a   Cacciapuoti, Marianna ^a   Lupoli, Gelsy Arianna ^a   Tarantino, Paolo ^a   Nasto, Aurelio ^b   Di Minno, Matteo Nicola Dario ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Department of Surgery Interventional Hepatology Unit Andrea Tortora Hospital   (Italy)

^c CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

Arterial stiffness; Flow mediated dilation; Intima media thickness; Primary aldosteronism; Pulse wave velocity; Subclinical atherosclerosis

Indexed keywords

ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; AUGMENTATION INDEX; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CASE CONTROL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FLOW MEDIATED DILATION; HEART RATE; HUMAN; NITRATE MEDIATED DILATION; PREVENTIVE MEDICINE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; SEX DIFFERENCE; SMOKING HABIT; SYSTEMATIC REVIEW; CARDIOVASCULAR DISEASES; HYPERALDOSTERONISM; HYPERTENSION; META ANALYSIS; PATHOPHYSIOLOGY; RISK FACTOR;

BIOLOGICAL MARKER;

BIOMARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; RISK FACTORS;

EID: 84959272939     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.01.200     Document Type: Article

References (59)

1. M. De Rosa, M. Galatola, L. Quaglietta, E. Miele, G. De Palma, G.B. Rossi, and et al. Alu-mediated genomic deletion of the serine/threonine protein kinase 11 (STK11) gene in Peutz-Jeghers syndrome Gastroenterology 138 2010 2558 2560
2. A. Hannemann, and H. Wallaschofski Prevalence of primary aldosteronism in patient's cohorts and in population-based studies - a review of the current literature Horm. Metab. Res. 44 2012 157 162
3. Y.Y. Chang, A. Chen, Y.H. Chen, C.S. Hung, V.C. Wu, X.M. Wu, and et al. Hypokalemia correlated with arterial stiffness but not microvascular endothelial function in patients with primary aldosteronism J. Renin-Angiotensin-Aldosterone Syst. 16 2015 353 359
4. S.H. Kim, J.H. Ahn, H.C. Hong, H.Y. Choi, Y.J. Kim, N.H. Kim, and et al. Changes in the clinical manifestations of primary aldosteronism Korean J. Intern. Med. 29 2014 217 225
5. P. Milliez, X. Girerd, P.F. Plouin, J. Blacher, M.E. Safar, and J.J. Mourad Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism J. Am. Coll. Cardiol. 45 2005 1243 1248
6. C. Catena, G. Colussi, E. Nadalini, A. Chiuch, S. Baroselli, R. Lapenna, and et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment Arch. Intern. Med. 168 2008 80 85
7. M. Reincke, E. Fischer, S. Gerum, and et al. Observational study mortality in treated primary aldosteronism: The German Conn's registry Hypertension 60 2012 618 624
8. C. Catena, G. Colussi, L. Marzano, and L.A. Sechi Aldosterone and the heart: from basic research to clinical evidence Horm. Metab. Res. 44 2012 181 187
9. R. Rocha, and J.W. Funder The pathophysiology of aldosterone in the cardiovascular system Ann. N. Y. Acad. Sci. 970 2002 89 100
10. C.B. Stehr, R. Mellado, M.P. Ocaranza, C.A. Carvajal, L. Mosso, E. Becerra, and et al. Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients J. Hypertens. 28 2010 2120 2126
11. J. Widimsky Jr., B. Strauch, O. Petrák, J. Rosa, Z. Somloova, T. Zelinka, and et al. Vascular disturbances in primary aldosteronism: clinical evidence Kidney Blood Press. Res. 35 2012 529 533
12. A. Simon, G. Chironi, and J. Levenson The performance of subclinical arterial disease detection as screening test for coronary heart disease Hypertension 48 2006 392 396
13. M.L. Bots, and D.E. Grobbee Intima media thickness as a surrogate marker for generalised atherosclerosis Cardiovasc. Drugs Ther. 16 2002 341 351
14. E. de Groot, G.K. Hovingh, A. Wiegman, P. Duriez, A.J. Smit, J.C. Fruchart, and et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis Circulation 109 2004 III33 III38
15. D.H. O'Leary, J.F. Polak, R.A. Kronmal, T.A. Manolio, G.L. Burke, and S.K. Wolfson Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group N. Engl. J. Med. 340 1999 14 22
16. L.E. Chambless, G. Heiss, A.R. Folsom, W. Rosamond, M. Szklo, A.R. Sharrett, and et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993 Am. J. Epidemiol. 146 1997 483 494
17. J. Calabia, P. Torguet, M. Garcia, I. Garcia, N. Martin, B. Guasch, and et al. Doppler ultrasound in the measurement of pulse wave velocity: Agreement with the Complior method Cardiovasc. Ultrasound. 9 2011 13
18. T.H. Khan, A.F. Falahat, and K. Niazi Critical review of the ankle brachial index Curr. Cardiol. Rev. 4 2008 101 106
19. C. Vlachopoulos, K. Aznaouridis, and C. Stefanadis Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis J. Am. Coll. Cardiol. 55 2010 1318 1327
20. R.T. Ras, M.T. Streppel, R. Draijer, and P.L. Zock Flow-mediated dilation and cardiovascular risk prediction: A systematic review with meta-analysis Int. J. Cardiol. 168 2013 344 351
21. M.C1. Corretti, T.J. Anderson, E.J. Benjamin, D. Celermajer, F. Charbonneau, M.A. Creager, and et al. International Brachial Artery Reactivity Task Force Guidelines for the ultrasound assessment of endothelialdependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force J. Am. Coll. Cardiol. 39 2002 257 265
22. I.S. Mackenzie, I.B. Wilkinson, and J.R. Cockcroft Assessment of arterial stiffness in clinical practice QJM 95 2002 67 74
23. G. Bernini, F. Galetta, F. Franzoni, M. Bardini, C. Taurino, M. Bernardini, and et al. Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism J. Hypertens. 26 2008 2399 2405
24. R. Holaj, T. Zelinka, D. Wichterle, O. Petrák, B. Strauch, and J. Widimský Jr. Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension J. Hypertens. 25 2007 1451 1457
25. M.K. Nishizaka, M.A. Zaman, S.A. Green, K.Y. Renfroe, and D.A. Calhoun Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism Circulation 109 2004 2857 2861
26. K. Tsuchiya, T. Yoshimoto, and Y. Hirata Endothelial dysfunction is related to aldosterone excess and raised blood pressure Endocr. J. 56 2009 553 559
27. P.B. Mark, S. Boyle, L.U. Zimmerli, E.P. McQuarrie, C. Delles, and E.M. Freel Alterations in vascular function in primary aldosteronism: A cardiovascular magnetic resonance imaging study J. Hum. Hypertens. 28 2014 92 97
28. J. Rosa, Z. Somlóová, O. Petrák, B. Strauch, T. Indra, M. Senitko, and et al. Peripheral arterial stiffness in primary aldosteronism Physiol. Res. 61 2012 461 468
29. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement PLoS Med. 6 7 2009 e1000097
30. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P, Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical-epidemiology/oxford.htm.
31. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
32. J.A. Sterne, M. Egger, and G.D. Smith Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis BMJ 323 2001 101 105
33. S. Duval, and R. Tweedie Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
34. R. Holaj, J. Rosa, T. Zelinka, B. Štrauch, O. Petrák, T. Indra, and et al. Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness J. Hypertens. 33 2015 874 882
35. Y.H. Lin, L.Y. Lin, A. Chen, X.M. Wu, J.K. Lee, T.C. Su, and et al. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma Atherosclerosis 221 2012 154 159
36. B. Strauch, O. Petrák, T. Zelinka, D. Wichterle, R. Holaj, M. Kasalický, and et al. Adrenalectomy improves arterial stiffness in primary aldosteronism Am. J. Hypertens. 21 2008 1086 1092
37. C. Tsioufis, D. Tsiachris, K. Dimitriadis, P. Stougiannos, P. Missovoulos, A. Kakkavas, and et al. Myocardial and aortic stiffening in the early course of primary aldosteronism Clin. Cardiol. 31 2008 431 436
38. V.C. Wu, S.C. Lo, Y.L. Chen, and et al. Endothelial progenitor cells in primary aldosteronism: A biomarker of severity for aldosterone vasculopathy and prognosis J. Clin. Endocrinol. Metab. 96 2011 3175 3183
39. T. Matsumoto, K. Oki, M. Kajikawa, and et al. Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism Hypertension 65 2015 841 848
40. I. Martín-Timón, C. Sevillano-Collantes, A. Segura-Galindo, and F.J. Del Cañizo-Gómez Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J. Diabetes 5 2014 444 470
41. G.P. Rossi, V. Di Bello, C. Ganzaroli, A. Sacchetto, M. Cesari, A. Bertini, and et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism Hypertension 40 2002 23 27
42. G.P. Rossi, L.A. Sechi, G. Giacchetti, V. Ronconi, P. Strazzullo, and J.W. Funder Primary aldosteronism: cardiovascular, renal and metabolic implications Trends Endocrinol. Metab. 19 2008 88 90
43. D.A. Calhoun Aldosteronism and hypertension Clin. J. Am. Soc. Nephrol. 1 2006 1039 1045
44. A. McCurley, and I.Z. Jaffe Mineralocorticoid receptors in vascular function and disease Mol. Cell. Endocrinol. 350 2012 256 265
45. G.E. Callera, A.C. Montezano, A. Yogi, R.C. Tostes, Y. He, S. EL, and et al. c-Src dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats Hypertension 46 2005 1032 1038
46. H. Oberleithner, T. Ludwig, C. Riethmuller, U. Hillebrand, L. Albermann, C. Schäfer, and et al. Human endothelium: target for aldosterone Hypertension 43 2004 952 956
47. G.P. Rossi, A. Sacchetto, P. Visentin, C. Canali, G.R. Graniero, P. Palatini, and et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism Hypertension 27 1996 1039 1045
48. D. Rizzoni, E. Porteri, M. Castellano, G. Bettoni, M.L. Muiesan, P. Muiesan, and et al. Vascular hypertrophy and remodeling in secondary hypertension Hypertension 28 1996 785 790
49. D. Rizzoni, S. Paiardi, L. Rodella, E. Porteri, C. De Ciuceis, R. Rezzani, and et al. Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism J. Clin. Endocrinol. Metab. 91 2006 2638 2642
50. B.M. Schmidt, and R.E. Schmieder Aldosterone-induced cardiac damage: focus on blood pressure independent effects Am. J. Hypertens. 16 2003 80 86
51. A. Benetos, P. Lacolley, and M.E. Safar Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats (SHRs) Arterioscler. Thromb. Vasc. Biol. 17 1997 1152 1156
52. I.M. van der Meer, M.L. Bots, A. Hofman, A.I. del Sol, D.A. van der Kuip, and J.C. Witteman Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: The Rotterdam study Circulation 109 2004 1089 1094
53. P. Ambrosino, R. Lupoli, A. Di Minno, M. Tasso, R. Peluso, and M.N. Di Minno Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies Thromb. Haemost. 113 2015 916 930
54. M. De Rosa, M. Galatola, L. Quaglietta, E. Miele, G. De Palma, G.B. Rossi, and et al. Alu-mediated genomic deletion of the serine/threonine protein kinase 11 (STK11) gene in Peutz-Jeghers syndrome Gastroenterology 138 2010 2558 2560
55. E. Lewicka, J. Dudzińska-Gehrmann, A. Dabrowska-Kugacka, P. Zagozdzon, E. Stepnowska, A. Lizewska, and et al. Plasma biomarkers as predictors of recurrence of atrial fibrillation Pol. Arch. Med. Wewn. 125 2015 424 433
56. A. Buglioni, V. Cannone, S.J. Sangaralingham, D.M. Heublein, C.G. Scott, K.R. Bailey, and et al. Aldosterone predicts cardiovascular, renal, and metabolic disease in the general community: A 4-year follow-up J. Am. Heart Assoc. 4 2015 e002505
57. P. Ambrosino, M. Tasso, R. Lupoli, A. Di Minno, D. Baldassarre, E. Tremoli, and et al. Non-invasive assessment of arterial stiffness in patients with rheumatoid arthritis: A systematic review and meta-analysis of literature studies Ann. Med. 47 2015 457 467
58. M.N. Di Minno, P. Ambrosino, R. Lupoli, A. Di Minno, M. Tasso, R. Peluso, and et al. Clinical assessment of endothelial function in patients with rheumatoid arthritis: A meta-analysis of literature studies Eur. J. Intern. Med. 26 2015 835 842
59. M.N. Di Minno, P. Ambrosino, R. Lupoli, A. Di Minno, M. Tasso, R. Peluso, and et al. Cardiovascular risk markers in patients with psoriatic arthritis: A meta-analysis of literature studies Ann. Med. 47 2015 346 353